Analysis of Deaths and Favorable Developments of Patients with SARS-CoV-2 Hospitalized in the Largest Hospital for Infectious Diseases and Pneumo-Phthisiology in the West of the Country

Abstract

Purpose Romania is one of the European countries that has been hit the hardest by the severe acute respiratory syndrome caused by the new coronavirus SARS-CoV-2, with over 1.91 million reported cases and over 59,257 deaths. The aim of this study was to identify the main predictors of death in hospitalized patients. Patients and Methods In the period from 1 March 2020 to 30 June 2021, an observational, retrospective, randomized, case-control study was conducted, which included a sample of 139 patients who died in hospital and another sample of 275 patients who had been discharged in an improved or healed condition. Confirmation of COVID-19 cases was performed by RT-PCR from nasopharyngeal and oropharyngeal exudates. Statistical data were analyzed by logistic regression, Cox regression and a comparison of survival curves by the log-rank (Mantel-Cox) test. Results The most powerful logistic regression model identified the following independent predictors of death: history of coagulopathy HR = 30.73 [1.94–487.09], p = 0.015; high percentage of neutrophils HR = 1.09 [1.01–1.19], p = 0.027; and decreased blood-oxygenation HR = 53881.97 [1762.24–1647489.44], p < 0.001. Cox regression identified the following factors that influenced the evolution of cases: history of coagulopathy HR = 2.44 [1.38–4.35], p = 0.000; O 2 saturation HR = 0.98 [0.96–0.99], p = 0.043; serum creatinine HR = 1.23 [1.08–1.39], p = 0.001; dyspnea on admission HR = 2.99 [1.42–6.30], p = 0.004; hospitalization directly in the ICU HR = 3.803 [1.97–7.33], p < 0.001; heart damage HR = 16.76 [1.49–188.56], p = 0.022; and decreased blood-oxygenation HR = 35.12 [5.92–208.19], p < 0.001. Conclusion Knowledge of the predictors of death in hospitalized patients allows for the future optimization of triage and therapeutic case management for COVID-19.

Risk and extent of intracranial haemorrhage in patients with SARS-CoV-2 infection admitted to intensive care unit

“…As risk factors for mortality during treatment on ICU were found to be age over 65 years, renal failure requiring dialysis, the use of extracorporeal membrane oxygenation (ECMO) and mechanical ventilation. These risk factors are in accordance with the preexisting literature2,4,[9][10][11][12][13] . In a 2021 meta-analysis by Dessie et al, older age has shown increased risk of mortality due to coronavirus.…”

“…Although the SARS-Cov2 pandemic has mainly been overcome after more than three years, several neurological complications of the infection are still evident. Even today, there are still isolated cases of people who require treatment for severe COVID-19 infections and neurosurgery-related complications 2,3 .…”

Novel receptor, mutation, vaccine, and establishment of coping mode for SARS-CoV-2: current status and future

“…People of all ages are generally susceptible to SARS-CoV-2 because it is a novel pathogen, especially elderly individuals with underlying diseases (diabetes, cardiovascular and cerebrovascular diseases, malignant tumors, etc.) that readily cause complications and critical illness after infection and account for the vast majority of deaths ( Gao Y. et al, 2021 ; Laza et al, 2022 ). This suggests that there may be a close relationship between immunity and symptoms or manifestations of SARS CoV-2 infection and whether it will develop into severe disease.…”